Johnson & Johnson
NYSE: JNJ
$147.03
-$0.74 (-0.5%)
Closing Price on January 17, 2025
JNJ Articles
If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this Monday...
Published:
Last Updated:
According to MarketWatch, shares in Rio Tinto (RTP) dropped 40% after BHP Billiton (BHP) dropped its offer for the company. According to Reuters, Citigroup’s (C) assurances that it did not need...
Published:
Last Updated:
It looks as though not quite all the mergers are dead on the medical tech and biotechnology front. Johnson & Johnson (NYSE: JNJ) announced that it is acquiring Omrix Biopharmaceuticals, Inc....
Published:
Last Updated:
We have outlined the changes we have seen in the holdings of Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) and these were put into groups in alphabetical order from I to S for the quarter...
Published:
Last Updated:
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study...
Published:
Last Updated:
These are some of the other non-tech analyst upgrades and downgrades from Wall Street firms this Wednesday morning: Constellation Energy (CEG) Raised to Buy at Jefferies. Denny’s (DENN) Raised to...
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) is showing that some companies can get it right despite tough times. The company has beat earnings and is even raising its fiscal 2008 guidance. The consumer...
Published:
Last Updated:
The market needed Johnson & Johnson (JNJ) to come though with big numbers to show that the consumer goods and medical devices markets, which to a large extent depend on consumer healthcare, were...
Published:
Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number which is the average of all firms in the index is misleading. The market will be...
Published:
Last Updated:
A big up day in the market, say 4% or 5%, is not a rally, at least not any more. The DJIA has proved that it can move 1,000 points from bottom to top or top to bottom in one trading session. If...
Published:
Last Updated:
The list of management screw-ups at Boston Scientific (BSX) is almost too long to number. It bought rival Guidant and added $7 billion in debt in the process. Some of Guidant’s products were not as...
Published:
Last Updated:
According to Reuters, a Senate plan to vote on the bailout package pushed US markets up. Reuters reports that the FDIC would like to increase the value of the accounts it insures. Reuters reports...
Published:
Last Updated:
You know it’s a rough day in the market when even defensive stocks are weak or mixed. We are at least seeing a mixed bag from some of these. But the trend is a pretty easy one to see. Even...
Published:
The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs which keep clogged arteries open. Last year, several studies showed that stents could cause...
Published:
Last Updated:
Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical research community for over a year fighting the perception that its drug-coated stents...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.